Fractyl Health Reports Q3 2026 Net Loss of $14.2 Million and Positive Revita Trial Results

Fractyl Health reported a third-quarter 2026 net loss of $14.2 million, compared with $45.6 million a year earlier, while operating expenses declined to $18.6 million. The company said its REMAIN-1 pivotal cohort met its six-month weight-loss-retention endpoint, and it expects to submit a planned F…